3061 - 3070 of 8399 Results
Title
Year
-
OPENTitle: A comparative and comprehensive study of prediction of Parkinson’s diseaseJournal Name: Indonesian Journal of Electrical Engineering and Computer SciencePublisher: Institute of Advanced Engineering and ScienceVol: 23Issue #: 3Start Page: 1748End Page: 1748Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.11591/ijeecs.v23.i3.pp1748-1760Best OA location URL: http://ijeecs.iaescore.com/index.php/IJEECS/article/download/25890/15468Citation Count: 3
-
OPENTitle: Allied Healthcare ProfessionalsJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28794Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28794Citation Count: 32
-
OPENTitle: Carlos II of Spain, ‘The Bewitched’: cursed by aspartylglucosaminuria?Journal Name: BMJ Neurology OpenPublisher: BMJVol: 3Issue #: 2Start Page: e000072End Page: e000072Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjno-2020-000072Best OA location URL: https://neurologyopen.bmj.com/content/bmjno/3/2/e000072.full.pdfCitation Count: 1
- Clinical perception and management of Parkinson's disease during the COVID-19 pandemic: A Canadian experience2021OPENTitle: Clinical perception and management of Parkinson's disease during the COVID-19 pandemic: A Canadian experienceJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 66End Page: 76Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.08.018Best OA location URL: http://www.prd-journal.com/article/S1353802021003126/pdfCitation Count: 17
- Effect of the glycine transporter 1 inhibitor ALX-5407 on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset2021RESTRICTEDTitle: Effect of the glycine transporter 1 inhibitor ALX-5407 on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmosetJournal Name: European Journal of PharmacologyPublisher: Elsevier BVVol: 910Issue #:Start Page: 174452End Page: 174452Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejphar.2021.174452Citation Count: 14
- Is there a special relationship between complex I activity and nigral neuronal loss in Parkinson’s disease? A critical reappraisal2021RESTRICTEDTitle: Is there a special relationship between complex I activity and nigral neuronal loss in Parkinson’s disease? A critical reappraisalJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1767Issue #:Start Page: 147434End Page: 147434Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.brainres.2021.147434Best OA location URL: https://doi.org/10.1016/j.brainres.2021.147434Citation Count: 33
- Protein Transnitrosylation Signaling Networks Contribute to Inflammaging and Neurodegenerative Disorders2021RESTRICTEDTitle: Protein Transnitrosylation Signaling Networks Contribute to Inflammaging and Neurodegenerative DisordersJournal Name: Antioxidants & Redox SignalingPublisher: Mary Ann Liebert IncVol: 35Issue #: 7Start Page: 531End Page: 550Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1089/ars.2021.0081Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388249Citation Count: 22
- Reply to: “Experience with a New Index to Differentiate Parkinson's Disease and Progressive Supranuclear Palsy”2021RESTRICTEDTitle: Reply to: “Experience with a New Index to Differentiate Parkinson's Disease and Progressive Supranuclear Palsy”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2208End Page: 2209Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28725Citation Count: 0
- Reply to: “α‐Synuclein (SNCA) A30G Mutation as a Cause of a Complex Phenotype Without Parkinsonism”2021RESTRICTEDTitle: Reply to: “α‐Synuclein (SNCA) A30G Mutation as a Cause of a Complex Phenotype Without Parkinsonism”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2212End Page: 2213Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28742Citation Count: 0
-
RESTRICTEDTitle: Seeking progress in disease modification in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 90Issue #:Start Page: 134End Page: 141Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.09.006Citation Count: 10